...
首页> 外文期刊>Cardiology >Very Small Left Atrial Volume as a Marker for Mortality in Patients Undergoing Nongated Computed Tomography Pulmonary Angiography
【24h】

Very Small Left Atrial Volume as a Marker for Mortality in Patients Undergoing Nongated Computed Tomography Pulmonary Angiography

机译:非常小的左心房体积作为患者中患者的死亡率标志物,患有肺部肺血管造影

获取原文
获取原文并翻译 | 示例

摘要

Objectives: To evaluate the association between very small left atria (VSLA) on nongated computed tomography pulmonary angiography (CTPA) and mortality in patients without pulmonary embolism (PE). Methods: Patients who underwent nongated CTPA between 2011 and 2015 in order to rule out PE, and had an echocardiogram within 24 h of the CTPA, were retrospectively identified. The left atrial volume of nongated CTPA was calculated using automatic 4-chamber volumetric analysis software. The association between the lowest 5th percentile of the left atrial volume index, referred to as the VSLA group, and mortality was investigated after adjustment for age, gender, background diseases, and laboratory values. Results: The study cohort included 241 patients. Patients with VSLA had a left atrial volume index 24 mL/m(2) (n = 11). Demographics and background diseases did not differ between the study groups. The median follow-up was 22.7 months (IQR 0.03-54.3). VSLA was an independent predictor of mortality (HRadj = 3.6; 95% CI 1.46-8.87; p = 0.005), along with malignancy (HRadj = 2.28; 95% CI 1.32-3.93; p = 0.003) and lower hemoglobin (HR adj = 0.86; 95% CI 0.76-0.99; p = 0.032). Conclusions: Our findings suggest that VSLA on nongated CTPA may serve as a marker for mortality. The use of CTPA volumetric analysis can help risk stratification in patients with dyspnea and no PE. (C) 2017 S. Karger AG, Basel
机译:目的:评估Nongated计算断层摄影肺血管造影(CTPA)的非常小的左心房(VSLA)与没有肺栓塞患者的死亡率(PE)。方法:回顾性识别,在2011年和2015年间接受2011年和2015年之间的Nongated CTPA的患者,并在CTPA的24小时内进行了超声心电图。使用自动4室体积分析软件计算Ngated CTPA的左心房体积。在调整年龄,性别,背景疾病和实验室值后,研究了左心房卷指数的最低第5百分位数之间的关联和死亡率。结果:研究队列包括241名患者。 VSLA患者具有左心房载体指数& 24ml / m(2)(n = 11)。研究组之间的人口统计和背景疾病在没有区别。中位后续时间为22.7个月(IQR 0.03-54.3)。 VSLA是死亡率的独立预测因子(HRADJ = 3.6; 95%CI 1.46-8.87; p = 0.005),与恶性肿瘤(HRADJ = 2.28; 95%CI 1.32-3.93; p = 0.003)和低血红蛋白(HR adj = 0.86; 95%CI 0.76-0.99; P = 0.032)。结论:我们的研究结果表明Nongated CTPA上的VSLA可以作为死亡率的标志物。 CTPA体积分析的使用可以帮助呼吸困难患者的风险分层,没有PE。 (c)2017年S. Karger AG,巴塞尔

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号